Intravenous ketamine and progressive cholangiopathy in COVID-19 patients

Authors :: Vincent Mallet
Kilian Bock
Paul Doumbe Mandengue
Nicolas Dufour
Torsten Voigtlaender
Jean-Damien Ricard
Pierre Isnard
Vincent Frochot
Emmanuel Letavernier
Lucile Moga
Amandine Landrieux
Pierre-Emmanuel Rautou
Nathalie Pons-Kerjean
Anaïs Vallet-Pichard
Laurent Chouchana
Coralie Gernez
Carole Burger
Anne Scemla
Christian de Tymoski
François Depret
Emmanuel Dudoignon
Lionel Lamhaut
Rémi Flicoteau
Géraldine Rousseau
Jean-Paul Duong Van Huyen
Jean-Michel Correas
Heiner Wedemeyer
Stanislas Pol
Source :: Journal of Hepatology
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Male
Cholangiopathy
2019-20 coronavirus outbreak
Intravenous ketamine
Coronavirus disease 2019 (COVID-19)
Cholangitis
Biopsy
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Covid-19, Coronavirus infectious disease 2019
Bile Duct Diseases
AST, aspartate aminotransferase
UDCA, ursodeoxycholic acid
End Stage Liver Disease
ULN, upper limit of normal
Liver Function Tests
Cholestasis
Germany
ALT, alanine aminotransferase
medicine
Humans
GGT, gamma-glutamyl transferase
Ketamine
Letter to the Editor
Intrahepatic
Anesthetics, Dissociative
Duration of Therapy
Dose-Response Relationship, Drug
ALP, alkaline phosphatase
Hepatology
SARS-CoV-2
business.industry
Middle Aged
medicine.disease
Respiration, Artificial
Outcome and Process Assessment, Health Care
Anesthesia
Administration, Intravenous
Female
France
Drug Monitoring
Chemical and Drug Induced Liver Injury
Covid-19
business
MRI, magnetic resonance imaging
medicine.drug

Full Text Access

Tools